483
3D Imaging Drug Design and DevelopmentFDA 483 - 3D Imaging Drug Design and Development - June 09, 2025
Discuss this record with AI
Record Details
The provided content for the FDA 483 document is empty, consisting only of page number references. To generate a concise 150-300 word summary that includes the company name, inspection dates, main violations/issues, regulatory framework, and required actions, please provide the actual text of the FDA 483 document. Without the document content, a summary cannot be created.
Open in Dashboard
ID · d5154a2b-5adb-43eb-b8e3-da4daa333ba5